Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
Status: Completed
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 35
Healthy Volunteers: t
View:
• Female
• Aged 18-35 years, established by visual inspection of a government-issued ID
• Average menstrual cycle 21-35 days
Locations
United States
Illinois
University of Illinois Department of Pharmacy Practice
Chicago
Time Frame
Start Date: 2019-09-26
Completion Date: 2023-09-01
Participants
Target number of participants: 129
Treatments
Other: All Participants
Related Therapeutic Areas
Sponsors
Leads: University of Illinois at Chicago